Connection

Co-Authors

This is a "connection" page, showing publications co-authored by David Cole and Ernest Camp.
Connection Strength

0.762
  1. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016 Jan 11; 5:e182.
    View in: PubMed
    Score: 0.142
  2. The impact of surgical diversion before neoadjuvant therapy for rectal cancer. Am Surg. 2015 May; 81(5):444-9.
    View in: PubMed
    Score: 0.135
  3. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013 Sep; 206(3):289-95.
    View in: PubMed
    Score: 0.119
  4. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther. 2013 Apr; 20(4):222-8.
    View in: PubMed
    Score: 0.117
  5. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012 Oct; 204(4):428-33.
    View in: PubMed
    Score: 0.110
  6. Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. J Surg Res. 2012 Aug; 176(2):359-66.
    View in: PubMed
    Score: 0.107
  7. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.